The Efficacy of Eribulin Monotherapy after Anthracycline and Taxane in HER2-Negative Metastatic Breast Cancer

被引：0
|
作者：
Tsushita, Natsuko [1 ]
Shimoi, Tatsunori [1 ]
Kitano, Atsuko [1 ]
Shimomura, Akihiko [1 ]
Kodaira, Makoto [1 ]
Yunokawa, Mayu [1 ]
Yonemori, Kan [1 ]
Shimizu, Chikako [1 ]
Fujiwara, Yasuhiro [1 ]
Tamura, Kenji [1 ]
机构：
[1] Natl Canc Ctr, Dept Breast & Med Oncol, Tokyo, Japan
来源：
ANNALS OF ONCOLOGY | 2016年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2 - 025
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Efficacy study of sequential therapy with anthracycline, taxane, and eribulin in patients with HER2-negative locally advanced breast cancer (JBCRG-17).
    Kondo, Naoto
    Ito, Yoshinori
    Fukada, Ippei
    Ohtani, Shoichiro
    Hattori, Masaya
    Tokunaga, Eriko
    Matsunami, Nobuki
    Mashino, Kohjiro
    Kosaka, Taijiro
    Tanabe, Masahiko
    Yotsumoto, Daisuke
    Yamanouchi, Kosho
    Sawaki, Masataka
    Kashiwaba, Masahiro
    Kawabata, Hidetaka
    Kuroi, Katsumasa
    Morita, Satoshi
    Ohno, Shinji
    Toi, Masakazu
    Masuda, Norikazu
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [2] Efficacy and safety of eribulin plus carboplatin combination for HER2-negative metastatic breast cancer
    Ni, M.
    Zhou, L.
    Lu, Y.
    Zhang, L.
    Li, X.
    Chen, M.
    Yang, A.
    Zhang, L.
    Xu, F.
    Yuan, Z.
    Wang, S.
    Shi, Y.
    An, X.
    [J]. ANNALS OF ONCOLOGY, 2023, 34 : S1490 - S1490
  • [3] Capecitabine after anthracycline and taxane exposure in HER2-negative metastatic breast cancer patients: Response, survival, and prognostic factors
    Gilabert, M.
    Esterni, B.
    Bertucci, F.
    Viens, P.
    Goncalves, A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [4] Capecitabine after Anthracycline and Taxane Exposure in HER2-negative Metastatic Breast Cancer Patients: Response, Survival and Prognostic Factors
    Gilaberti, Marine
    Bertucci, Francois
    Esterni, Benjamin
    Madroszyk, Anne
    Tarpin, Carole
    Jacquemier, Jocelyne
    Extra, Jean-Marc
    Viens, Patrice
    Goncalves, Anthony
    [J]. ANTICANCER RESEARCH, 2011, 31 (03) : 1079 - 1086
  • [5] EFFICACY AND SAFETY OF ERIBULIN IN PATIENTS WITH HER2-NEGATIVE METASTATIC BREAST CANCER: REAL LIFE EXPERIENCE
    Zhilyaeva, Larisa
    [J]. BREAST, 2017, 36 : S53 - S54
  • [6] Efficacy of taxane rechallenge in early metastatic relapse of HER2-negative breast cancer patients previously treated with taxane
    Vasseur, A.
    Carton, M.
    Guiu, S.
    Augereau, P.
    Uwer, L.
    Reynier, M. A. Mouret
    Levy, C.
    Eymard, J- C.
    Goncalves, A.
    Robert, M.
    Rouge, T. De La Motte
    Bachelot, T.
    Petit, T.
    Debled, M.
    Grinda, T.
    Desmoulins, I.
    Vanlemmens, L.
    Dalenc, F.
    Simon, G.
    Cabel, L.
    [J]. ANNALS OF ONCOLOGY, 2021, 32 : S501 - S502
  • [7] A retrospective comparison of eribulin and capecitabine in patients with HER2-negative metastatic breast cancer
    Tsushita, N.
    Shimoi, T.
    Okuma, H. S.
    Kawachi, A.
    Kitano, A.
    Nishikawa, T.
    Shimomura, A.
    Noguchi, E.
    Kodaira, M.
    Yunokawa, M.
    Yonemori, K.
    Shimizu, C.
    Fujiwara, Y.
    Tamura, K.
    [J]. ANNALS OF ONCOLOGY, 2016, 27
  • [8] Safety and efficacy of eribulin as second-line treatment for HER2-negative metastatic breast cancer.
    Michalaki, Vasiliki
    Psychogios, John
    Contis, John
    Kondi, Agathi
    Gennatas, Constantine
    Papadimitriou, Christos A.
    Vasiliou, John
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [9] Efficacy of capecitabine monotherapy as the first-line treatment of metastatic HER2-negative breast cancer
    Babacan, Taner
    Efe, Orhan
    Hasirci, Ahmet S.
    Demirci, Fatih
    Buyukhatipoglu, Hakan
    Balakan, Ozan
    Sarici, Furkan
    Kertmen, Neyran
    Esin, Ece
    Akin, Serkan
    Ates, Ozturk
    Aksoy, Sercan
    Sever, Ali R.
    Altundag, Kadri
    [J]. TUMORI JOURNAL, 2015, 101 (04): : 418 - 423
  • [10] Combination chemotherapy with mitomycin C and methotrexate is active against metastatic HER2-negative breast cancer even after treatment with anthracycline, taxane, capecitabine, and vinorelbine
    Fukuda, Takayo
    Tanabe, Masahiko
    Kobayashi, Kokoro
    Fukada, Ippei
    Takahashi, Shunji
    Iwase, Takuji
    Ito, Yoshinori
    [J]. SPRINGERPLUS, 2015, 4
12345